Alex Rodriguez has issued a statement in response to the report in the Miami New Times today in which patient records were released suggesting that he used performance enhancing drugs as recently as 2012:
“The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch’s patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story — at least as they relate to Alex Rodriguez — are not legitimate.”
This is a clear attack on the patient records released as unreliable. Earlier, Major League Baseball released its own statement:
“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances. These developments, however, provide evidence of the comprehensive nature of our anti-drug efforts. Through our Department of Investigations, we have been actively involved in the issues in South Florida. It is also important to note that three of the players allegedly involved have already been disciplined under the Joint Drug Program.
“The recommendations of the Mitchell Report have once again played a critical role in Major League Baseball’s ongoing efforts against performance-enhancing drugs. MLB implemented all of the recommendations made by Senator Mitchell in 2007, several of which emphasized the significance of installing proactive investigative services.
“The establishment of our Department of Investigations has represented a critical advance in these comprehensive efforts. In the years since its formation, DOI’s work has proven pivotal to bringing to light information regarding the use of performance-enhancing substances. Furthermore, DOI has built strong working relationships with federal and local law enforcement authorities. These relationships are crucial because only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs.
“Vigilance remains the key toward protecting the integrity of our game. We have the best and most stringent drug testing policy in professional sports, we continue to work with our doctors and trainers to learn what they are seeing day-to-day and we educate our players about the game’s unbending zero-tolerance approach. We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game.
“We are in the midst of an active investigation and are gathering and reviewing information. We will refrain from further comment until this process is complete.”
With this, we are left with a he-said, he-said. It will take more investigation by Major League Baseball and the DEA in order to determine what the significance is of the patient records reported on in the Miami New Times is, if any.
Dallas Keuchel‘s agent Darek Braunecker told MLB Network Radio in early January that he had not engaged in any long-term contract negotiations with the Astros’ front office. Two weeks later, the sides reached a one-year, $7.25 million agreement, avoiding a salary arbitration hearing. So was a bigger financial commitment ever discussed?
Evan Drellich of the Houston Chronicle has the answer, writing in his offseason review that the “Astros and Keuchel have had substantial talks about extensions [this winter] … but to no avail.”
Keuchel carries all the leverage in the world after winning the 2015 American League Cy Young Award with a 2.48 ERA, 1.017 WHIP, and 216/51 K/BB ratio in 232 innings. He also made three appearances in the postseason to a 2.57 ERA in 14 frames.
Keuchel’s $7.25 million salary for 2016 will be a record for a player in his first year of arbitration eligibility. Locking up some of his free agent years (2019, 2020, 2021, etc.) would likely take a commitment of $120 million or more.
Houston has the 28-year-old left-hander under contractual control through 2018, and it sounds like the plan is to go season-to-season with his salaries.
He’ll remain a huge value to a good-looking Astros team.
Yadier Molina underwent surgery to repair a ligament tear in his right thumb shortly after the Cardinals were eliminated from the NLDS by the Cubs, and then he needed a followup procedure two months later.
It’s been an offseason of rest and rehab for the seven-time All-Star and eight-time Gold Glover, though he’s about ready to ramp up the intensity of workouts with the beginning of spring training approaching …
Brayan Pena was signed to a two-year, $5 million free agent contract this winter to provide more reliable depth behind the plate. He’ll be the Cardinals’ starter at catcher come Opening Day if Yadi isn’t quite ready.
Molina started a whopping 131 games behind the plate in 2015.
You’ve heard the stories by now. Jose Fernandez does not get along with Marlins management and is doubtful to sign a long-term contract with the team.
There’s still time for those relationships to be repaired — Fernandez can’t become a free agent until after the 2018 season — but we also have a monetary issue at play.
Barry Jackson of the Miami Herald writes Sunday that the Marlins are “under the impression” Fernandez and his representatives want $30 million per year on a long-term deal, a figure the Marlins “have no plans to meet.”
If the Marlins won’t pay, Fernandez and his reps will seek that number when the ace right-hander reaches free agency. That could be the same offseason Bryce Harper tries for $500 million.
A friend of Fernandez told Jackson that the 23-year-old native of Cuba was upset about some of the trades the Marlins made last summer and the removal of pitching coach Chuck Hernandez. You probably heard talk of Miami shopping Fernandez this winter, but the asking price was predictably sky-high.
Fernandez has been limited to 19 starts over the last two years because of Tommy John surgery and a biceps injury, but he boasts a stellar 2.40 ERA, 1.01 WHIP, and 10.5 K/9 in 289 career major league frames. He will make $2.8 million in 2016 and carries two more years of arbitration eligibility.
If he can put together a run of 30-start, 200-inning seasons, Fernandez will get that $30 million per year and probably much more.
Paul Hoynes at the Cleveland Plain Dealer has an in-depth look at how the Indians will manage their outfield during the early part of the 2016 season, in the absence of star Michael Brantley.
Brantley underwent labrum surgery on his right shoulder this past November and has not picked up a bat all winter. “In the off-season people know I love to hit,” Brantley acknowledged to Hoynes late last week. ”I hit a lot. It’s just been a change in my timetable.”
Hoynes says the projected date for Brantley’s 2016 debut is “hazy,” guessing that it might happen around late April or early May if everything continues to go smoothly. Shoulders can be tricky, for hitters and pitchers.
Rajai Davis, Abraham Almonte, and Lonnie Chisenhall figure to make up Cleveland’s primary starting outfield while Brantley is finishing his rehabilitation. Collin Cowgill and Joey Butler could also be in the mix. It’s a lacking group, tasked with replacing one of the most productive players in baseball.
Brantley, 28, has slashed .319/.382/.494 over the last two seasons, tallying 35 home runs, 90 doubles, 181 RBI, and 38 stolen bases in 293 games.
Could the talented Tribe be in for another slow start?
Shouldn’t this club be spending more money?